Statements (16)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:biotechnology
|
gptkbp:CEO |
gptkb:Peter_Greenleaf
|
gptkbp:country |
gptkb:Canada
|
gptkbp:developsDrugFor |
lupus nephritis
|
gptkbp:focusesOn |
autoimmune diseases
renal diseases |
gptkbp:foundedYear |
1993
|
gptkbp:headquartersLocation |
gptkb:Victoria,_British_Columbia,_Canada
|
https://www.w3.org/2000/01/rdf-schema#label |
Aurinia Pharmaceuticals
|
gptkbp:industry |
pharmaceuticals
|
gptkbp:notableProduct |
gptkb:Lupkynis
|
gptkbp:tradedOn |
gptkb:NASDAQ:AUPH
gptkb:TSX:AUP |
gptkbp:website |
https://www.auriniapharma.com/
|
gptkbp:bfsParent |
gptkb:Sofinnova_Investments
|
gptkbp:bfsLayer |
6
|